| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3343337 | Best Practice & Research Clinical Rheumatology | 2008 | 13 Pages |
Abstract
The analysis of synovial biomarkers is increasingly used in the context of innovative trial design in rheumatoid arthritis (RA). This approach, which is generally well tolerated by patients, has been used to provide insight into the pathogenesis of RA and the mechanism of action of therapy, as well as for screening purposes during early drug development.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Daniëlle M. Gerlag, Paul P. Tak,